DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



A Cognitive Behavioral Therapy-Based Text Message Intervention for Methamphetamine Dependence

Information source: California Pacific Medical Center Research Institute
ClinicalTrials.gov processed this data on August 20, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Amphetamine-Related Disorders

Intervention: CBT- based SMS text messaging intervention (Behavioral); CBT group therapy (Behavioral)

Phase: N/A

Status: Recruiting

Sponsored by: California Pacific Medical Center Research Institute

Official(s) and/or principal investigator(s):
Gantt Galloway, PharmD, Principal Investigator, Affiliation: California Pacific Medical Center

Overall contact:
Kathleen Garrison, Phone: 415-600-3126, Email: garrisk@cpmcri.org

Summary

This Phase I behavior therapy development study seeks to improve treatment outcomes for methamphetamine (MA)-dependent subjects by developing a novel cognitive behavioral therapy- (CBT-) based short message service (SMS) text messaging intervention.

Clinical Details

Official title: A Cognitive Behavioral Therapy-Based Text Message Intervention for Methamphetamine Dependence

Study design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment

Primary outcome: Proportion of MA-negative urine samples between the 2-week CBT text period and the 2-week control period

Eligibility

Minimum age: 18 Years. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria:

- English-speaking adults ≥ 18 years who are seeking treatment for MA addiction.

- Own a cellular phone with SMS text messaging capability and have an unlimited text

messaging plan.

- Available to attend CBT therapy groups.

- Agreeable to conditions of the study and signed an informed consent form.

Exclusion Criteria:

- Projected to be unavailable > 12 hours/day to read and send text messages.

- Any medical or psychosocial condition that would preclude safe, useful, or consistent

participation,

Locations and Contacts

Kathleen Garrison, Phone: 415-600-3126, Email: garrisk@cpmcri.org

New Leaf Treatment Center, Lafayette, California 94549, United States; Recruiting
Kathleen Garrison, Phone: 415-600-1652, Email: garrisk@cpmcri.org

Addiction & Pharmacology Research Laboratory, San Francisco, California 94107, United States; Not yet recruiting
Kathleen Garrison, Phone: 415-600-1652, Email: garrisk@cpmcri.org

Additional Information

clinical site at which patients are seen

Starting date: May 2014
Last updated: May 12, 2014

Page last updated: August 20, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017